The global surgical robotics market size is expected to surpass around USD 45.93 billion by 2034 and is growing at a CAGR of 13.9% over the forecast period 2025 to 2034.
The global shortage of physicians and surgeons, coupled with the increasing use of automated surgical instruments, is fueling market growth. Additionally, technological advancements, growing investments from regional and global stakeholders, and the rise in chronic conditions, particularly related to knee and hip replacement surgeries, are contributing to this trend. According to the American College of Rheumatology, the U.S. performs about 790,000 total knee replacements and 544,000 hip replacements annually, with these numbers continuing to rise as the population ages.
Furthermore, a study published by the American Academy of Orthopedic Surgeons (AAOS) in November 2024 reported that over 3.7 million total hip and knee replacement surgeries were performed between 2012 and 2023 across 1,447 facilities in the U.S. and the District of Columbia.
Key Takeaways
- The U.S. surgical robotics market size was reached at USD 4.71 billion in 2024 and is projected to hit around USD 17.32 billion by 2034.
- The North America has accounted revenue share of 50.27% in 2024.
- The Europe has captured revenue share of 22.42% in 2024.
- By application, the orthopedic surgery segment has leading the market in 2024.
- By application, the neurosurgery segment is expected grow at the fastest CAGR during the forecast period.
The benefits of these procedures, including reduced pain and blood loss, shorter recovery times, lower risk of infections, and smaller scars, are further driving market growth. For example, a study by the Hip and Knee Society comparing 90-day care costs for patients who underwent Mako total knee replacements versus traditional knee surgeries showed a cost saving of USD 2,400 for Mako patients. The same study also noted a 33% reduction in 90-day readmissions for Mako patients.
The increasing prevalence of bone degenerative diseases like arthritis and osteoporosis is also driving the demand for hip and knee replacement surgeries. Osteoporosis affects around 10 million people in the U.S. and 75 million people across the U.S., Europe, and Japan. Projections suggest that by 2040, one in four adults in the U.S. (78.4 million people) will have doctor-diagnosed arthritis, with one in nine adults (34.6 million) experiencing arthritis-related activity limitations. As demand for joint replacement surgeries rises, robotic-assisted surgery is improving precision, reducing recovery times, and enhancing patient outcomes.
Moreover, the growing prevalence of chronic diseases, including heart disease and cancer, is further expanding the market. The World Health Organization’s report from February 2024 revealed over 20 million new cancer cases worldwide, with 53.5 million people surviving at least five years post-diagnosis.
Investments from both local and international players in advanced surgical robots are positively impacting market growth. Enhancements in surgical navigation, particularly through Surgical Navigation Systems, are driving innovation. High-definition 3D cameras and augmented reality overlays provide surgeons with an immersive view of the surgical area, enhancing spatial awareness and decision-making. For instance, in February 2024, CMR Surgical launched its vLimeLite, an integrated fluorescence imaging system that improves visualization during surgeries by using Indocyanine Green (ICG), a fluorescent dye that helps visualize blood flow and tissue perfusion.
Additionally, the American College of Surgeons reported in May 2023 that more than 12 million surgeries have been performed globally using da Vinci systems, highlighting the widespread acceptance of robotic-assisted surgical technologies. The 22% increase in surgeries using these systems from 2022 to 2023 reflects the growing shift toward minimally invasive techniques that improve patient outcomes and reduce recovery times.
The surgical robots market is characterized by continuous innovation. Recent advancements in medical robotic systems have enhanced dexterity, precision, and visualization, allowing surgeons to perform intricate procedures with minimal tissue damage. For instance, in February 2023, CK Birla Hospital in India introduced fully active robotic technology for minimally invasive knee replacement surgeries, which helps assess deformities, create 3D pre-plans, and deliver precise surgical results for better outcomes.
The industry is also experiencing moderate merger and acquisition activity. Companies are seeking to expand their businesses to cater to the increasing demand for robotic surgery. For example, in August 2024, Asensus Surgical acquired Karl Storz, a leading manufacturer of endoscopic equipment, to bolster its capabilities in minimally invasive surgery by integrating Karl Storz’s expertise in visualization technologies.
Surgical robots, or robotic-assisted surgery devices, are approved by the FDA in the U.S. and by the EU & CEA in Europe. Certification by these authorities is essential for commercialization in the U.S. and the 27 EU nations. Securing FDA 510(k) premarket approval and the CE Mark can be time-consuming and costly but is a critical step for product marketing.
Several companies are launching new products and securing regulatory approvals to strengthen their market positions. For instance, in November 2024, Johnson & Johnson MedTech received FDA approval for its OTTAVA robotic surgical system, allowing the company to begin clinical trials with this advanced technology.
Application Insights
In 2024, the orthopedics segment held a significant revenue share. The increasing prevalence of musculoskeletal disorders like rheumatoid arthritis, osteoarthritis, osteoporosis, and lower back pain, as well as rising competition in the market, are driving this growth. Leading medical tech companies are advancing in the orthopedic robotics sector. For example, in July 2024, Stryker set a record for Mako orthopedic robot installations, designed to assist surgeons with joint replacement surgeries. This achievement highlights robust demand for robotic systems, with more than 76,900 knee and hip replacement procedures performed by Mako systems in 2018.
The neurology segment is expected to grow at the fastest rate, driven by the rising incidence of neurological disorders and the demand for minimally invasive brain surgeries. For instance, the ROSA ONE Brain robotic platform is widely used for minimal-invasive brain procedures. Additionally, ZEISS launched the KINEVO 900 S in September 2024, a cutting-edge Robotic Visualization System specifically designed for neurosurgery.
End-Use Insights
The inpatient (hospital) segment dominated the market, accounting for about 53% of revenue in 2024, as healthcare facilities increasingly adopt robotic technologies for enhanced precision and improved patient outcomes. In January 2025, Prashanth Hospitals launched a state-of-the-art Institute of Robotic Surgery, marking a significant technological advancement in healthcare. The outpatient (ASCs, surgical centers) segment is projected to grow at the fastest rate due to the benefits of minimally invasive and precise surgeries that result in quicker recovery and reduced healthcare costs.
Surgical Robots Market Regional Insights
North America:
North America dominated the global surgical robots market with a 50.27% revenue share in 2024. Continuous R&D efforts focused on improving ergonomics for better learning curves, as well as the adoption of minimally invasive surgery techniques, are expected to drive further growth. A notable milestone was the successful completion of North America’s first commercial surgery using the Medtronic Hugo robotic-assisted surgery system at Toronto General Hospital in April 2023.
U.S. Market Trends:
The U.S. surgical robots market led North America in 2024, driven by the adoption of minimally invasive procedures aimed at reducing recovery times. The country’s strong healthcare infrastructure and continuous advancements in robotic technologies are expected to propel the market forward.
Europe:
Europe’s surgical robots market is poised for significant growth, supported by well-established healthcare systems and favorable reimbursement policies. Germany, in particular, is expected to see considerable growth due to its robust healthcare infrastructure and government initiatives for local robotic production.
Asia Pacific:
The Asia Pacific region is expected to grow at the fastest pace due to government initiatives encouraging the adoption of advanced medical technologies. Countries like Japan, Singapore, and South Korea are leaders in healthcare technology adoption, while emerging markets like China and India are showing increasing demand for robotic systems.
China Market Trends:
China’s surgical robots market is set for substantial growth, with the modernization of domestic manufacturing and partnerships with global companies driving advancements. The successful remote surgeries conducted in January 2025 using robotic systems and satellite technology highlight China’s leadership in innovation.
Latin America:
The Latin American surgical robots market is expected to grow steadily, fueled by the increasing prevalence of chronic diseases and the availability of newer technologies. Brazil is projected to see significant growth due to rising healthcare expenditures and the adoption of advanced medical technologies.
Middle East & Africa:
The Middle East and Africa surgical robots market is expected to witness notable growth, driven by the high incidence of cancer and the need for skilled professionals. South Africa is expected to see growth as the introduction of robotic technology like the Da Vinci Surgical Robot enhances access to advanced medical services.
Read more insights@ https://www.cervicornconsulting.com/surgical-robots-market
